Anthony H Nguyen

Array ( [id] => 7634887 [patent_doc_number] => 06656731 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-12-02 [patent_title] => 'Nucleic acid catalysts with endonuclease activity' [patent_app_type] => B1 [patent_app_number] => 09/479005 [patent_app_country] => US [patent_app_date] => 2000-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 42371 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/656/06656731.pdf [firstpage_image] =>[orig_patent_app_number] => 09479005 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4407079 [patent_doc_number] => 06300098 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-09 [patent_title] => 'Human signal transduction serine/threonine kinase' [patent_app_type] => 1 [patent_app_number] => 9/468442 [patent_app_country] => US [patent_app_date] => 1999-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24661 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/300/06300098.pdf [firstpage_image] =>[orig_patent_app_number] => 468442 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4409706 [patent_doc_number] => 06300321 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-09 [patent_title] => 'Compounds, preparation and use for transferring nucleic acids into cells' [patent_app_type] => 1 [patent_app_number] => 9/424380 [patent_app_country] => US [patent_app_date] => 1999-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 15 [patent_no_of_words] => 13036 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 408 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/300/06300321.pdf [firstpage_image] =>[orig_patent_app_number] => 424380 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4356070 [patent_doc_number] => 06291668 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-18 [patent_title] => 'Oligonucleotide derivatives' [patent_app_type] => 1 [patent_app_number] => 9/445486 [patent_app_country] => US [patent_app_date] => 1999-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11370 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/291/06291668.pdf [firstpage_image] =>[orig_patent_app_number] => 445486 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6870585 [patent_doc_number] => 20030083275 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-01 [patent_title] => 'ANTISENSE OLIGODEOXYNUCLEOTIDES REGULATING EXPRESSION OF TNF ALPHA' [patent_app_type] => new [patent_app_number] => 09/439429 [patent_app_country] => US [patent_app_date] => 1999-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11286 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0083/20030083275.pdf [firstpage_image] =>[orig_patent_app_number] => 09439429 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1349801 [patent_doc_number] => 06579973 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-06-17 [patent_title] => 'Compositions for the treatment and diagnosis of breast cancer and methods for their use' [patent_app_type] => B1 [patent_app_number] => 09/433826 [patent_app_country] => US [patent_app_date] => 1999-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 67387 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/579/06579973.pdf [firstpage_image] =>[orig_patent_app_number] => 09433826 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1288369 [patent_doc_number] => 06632667 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-10-14 [patent_title] => 'Modulation of L-selectin shedding via inhibition of tumor necrosis factor- converting enzyme (TACE)' [patent_app_type] => B1 [patent_app_number] => 09/429096 [patent_app_country] => US [patent_app_date] => 1999-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16724 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/632/06632667.pdf [firstpage_image] =>[orig_patent_app_number] => 09429096 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1340758 [patent_doc_number] => 06586238 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-01 [patent_title] => 'Enzymatic nucleic acids containing 5-and or 3-cap structures' [patent_app_type] => B1 [patent_app_number] => 09/419125 [patent_app_country] => US [patent_app_date] => 1999-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 24 [patent_no_of_words] => 20101 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 125 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/586/06586238.pdf [firstpage_image] =>[orig_patent_app_number] => 09419125 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 690816 [patent_doc_number] => 07074768 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-07-11 [patent_title] => 'Modified protein kinase A-specific oligonucleotides and methods of their use' [patent_app_type] => utility [patent_app_number] => 09/412947 [patent_app_country] => US [patent_app_date] => 1999-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 19058 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 141 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/074/07074768.pdf [firstpage_image] =>[orig_patent_app_number] => 09412947 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7636486 [patent_doc_number] => 06380171 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-30 [patent_title] => 'Pro-protein converting enzyme' [patent_app_type] => B1 [patent_app_number] => 09/214555 [patent_app_country] => US [patent_app_date] => 1999-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 28 [patent_no_of_words] => 13755 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/380/06380171.pdf [firstpage_image] =>[orig_patent_app_number] => 09214555 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4409636 [patent_doc_number] => 06310047 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-30 [patent_title] => 'High affinity DNA binding compounds as adjuvants in antisense technology' [patent_app_type] => 1 [patent_app_number] => 9/379718 [patent_app_country] => US [patent_app_date] => 1999-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9671 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/310/06310047.pdf [firstpage_image] =>[orig_patent_app_number] => 379718 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4385487 [patent_doc_number] => 06277982 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-21 [patent_title] => 'Alkylation of alcohols, amines, thiols and their derivatives by cyclic sulfate intermediates' [patent_app_type] => 1 [patent_app_number] => 9/378665 [patent_app_country] => US [patent_app_date] => 1999-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 15 [patent_no_of_words] => 19822 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/277/06277982.pdf [firstpage_image] =>[orig_patent_app_number] => 378665 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 953827 [patent_doc_number] => 06958240 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-10-25 [patent_title] => 'Inhibition of major groove DNA binding proteins by modified polyamides' [patent_app_type] => utility [patent_app_number] => 09/374704 [patent_app_country] => US [patent_app_date] => 1999-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 19 [patent_no_of_words] => 13355 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 123 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/958/06958240.pdf [firstpage_image] =>[orig_patent_app_number] => 09374704 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7629553 [patent_doc_number] => 06818803 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-11-16 [patent_title] => 'Transgenic plants as an alternative source of lignocellulosic-degrading enzymes' [patent_app_type] => B1 [patent_app_number] => 09/373272 [patent_app_country] => US [patent_app_date] => 1999-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 14 [patent_no_of_words] => 16829 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/818/06818803.pdf [firstpage_image] =>[orig_patent_app_number] => 09373272 [rel_patent_id] =>[rel_patent_doc_number] =>)